Retaining Ravi Kiron, Ph.D., a co-founder in C2N and the former Chief Business Officer at Kinemed, Inc., to serve as Senior Vice President of Business Development where he is being tasked with sourcing additional biomarker services agreements for our Alzheimer’s assays; https://www.linkedin.com/pub/ravi-kiron/0/557/487